Clinical Trial Detail

NCT ID NCT03267836
Title Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

meningioma

Therapies

Avelumab

Age Groups: adult senior

No variant requirements are available.